ABNORMAL CYTOKINE SERUM LEVELS CORRELATE WITH IMPAIRED CELLULAR IMMUNE-RESPONSES AFTER SURGERY

被引:78
作者
BAXEVANIS, CN
PAPILAS, K
DEDOUSSIS, GVZ
PAVLIS, T
PAPAMICHAIL, M
机构
[1] HELLENIC ANTICANC INST, DEPT CLIN ANESTHESIA, GR-11522 ATHENS, GREECE
[2] HELLENIC ANTICANC INST, DEPT SURG, GR-11522 ATHENS, GREECE
来源
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY | 1994年 / 71卷 / 01期
关键词
D O I
10.1006/clin.1994.1055
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Serum levels of the interleukins (IL)-2, -1 beta, and -6, tumor-necrosis factor alpha (TNF-alpha), and prostaglandine E2 (PGE2) were measured serially before and after operation in patients undergoing various surgical procedures. Peripheral blood mononuclear cells (PBMC) from the same patients were analyzed before and after surgery for proliferative responses in the autologous mixed lymphocyte reaction (AMLR) and for cytolytic activity against the natural killer (NK)-sensitive K562 cell line. In patients who had major surgery, a decrease in IL-2 levels and increases in IL-1 beta, TNF-alpha, IL-6, and PGE2 levels were observed up to 9 days after the operation compared to those of the preoperative values. Decreased AMLR responses and NK activity were also observed in PBMC collected 5 days after surgery. All these changes were more intense in patients who had undergone major surgical procedures of increasing severity (i.e., cancer patients). Similar, although weaker, changes in cytokine serum levels, AMLR responses, and NK activity were also observed in patients undergoing minor surgery. Our data suggest that changes in cytokine serum levels may cause cellular immune dysfunctions, particularly in patients undergoing major surgery, and provide the basis for immune intervention in order to avoid infections occurring after major surgery. (C) 1994 Academic Press, Inc.
引用
收藏
页码:82 / 88
页数:7
相关论文
共 47 条
[1]  
ADERKA D, 1985, LANCET, V2, P1190
[2]   IMPAIRED GENERATION OF HIGH-AFFINITY INTERLEUKIN-2 RECEPTORS IN THE AUTOLOGOUS MIXED LYMPHOCYTE-REACTION IN RHEUMATOID-ARTHRITIS [J].
AKASU, F ;
POPLONSKI, L ;
SNOW, KM ;
VOLPE, R ;
KEYSTONE, EC .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (02) :142-147
[3]  
AKIYOSHI T, 1985, CLIN EXP IMMUNOL, V59, P45
[4]  
ANASTASOPOULOS E, 1992, ANTICANCER RES, V12, P489
[5]   DEPRESSED LEVELS OF GRANULAR LYMPHOCYTES WITH NATURAL-KILLER (NK) CELL-FUNCTION IN 247 CANCER-PATIENTS [J].
BALCH, CM ;
TILDEN, AB ;
DOUGHERTY, PA ;
CLOUD, GA ;
ABO, T .
ANNALS OF SURGERY, 1983, 198 (02) :192-199
[6]   SERUM LEVELS OF INTERLEUKIN-6, A POTENT MYELOMA CELL-GROWTH FACTOR, AS A REFLECT OF DISEASE SEVERITY IN PLASMA-CELL DYSCRASIAS [J].
BATAILLE, R ;
JOURDAN, M ;
ZHANG, XG ;
KLEIN, B .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (06) :2008-2011
[7]   PROTHYMOSIN-ALPHA RESTORES DEPRESSED ALLOGENEIC CELL-MEDIATED LYMPHOLYSIS AND NATURAL-KILLER-CELL ACTIVITY IN PATIENTS WITH CANCER [J].
BAXEVANIS, CN ;
RECLOS, GJ ;
PAPAMICHAIL, M .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (02) :264-268
[8]  
BAXEVANIS CN, 1992, J IMMUNOL, V148, P1979
[9]   PROTHYMOSIN-ALPHA ENHANCES HLA-DR ANTIGEN EXPRESSION ON MONOCYTES FROM PATIENTS WITH MULTIPLE-SCLEROSIS [J].
BAXEVANIS, CN ;
ANASTASOPOULOS, E ;
RECLOS, GJ ;
PAPAMICHAIL, M .
JOURNAL OF NEUROIMMUNOLOGY, 1990, 27 (2-3) :141-147
[10]  
BAXEVANIS CN, 1990, J IMMUNOL, V144, P4166